Owning Qantas Airways Ltd (ASX: QAN) shares has been a solid choice for passive income in recent times, following the COVID-19 pandemic. Investors may be wondering what the upcoming dividends could be for shareholders.

It has been a volatile decade for the airline so far, with the Middle East events causing a big increase in fuel prices for the airline.

As we saw in the FY26 result, the company reported that was a Middle East net impact of $420 million, leading to an underlying profit before tax falling $330 million to $2.06 billion and statutory net profit after tax dropped $316 million.

This allowed the business to pay a FY26 final dividend of $300 million (19.8 cents per share), which combined with its $300 million interim dividend.

Let’s take a look at what analysts think could happen with the dividends in the coming years.

FY27

We are already a few months into the 2027 financial year, and we still don’t know how the situation in the Middle East will play out or how long it could take. Travel demand and fuel prices could be significantly impacted, so we’ll have to see what happens next.

When Qantas announced its FY27 result, the airline gave some outlook commentary, which gave some insight into what could happen during this new financial year.

The airline said that travel demand remains resilient as customers continue to prioritise travel. International demand across Qantas and Jetstar remains “strong”, supported by customers redirecting travel away from the Middle East, while domestic demand is tracking “broadly in line with the fourth quarter of FY26.”

Qantas said that domestic and international total unit revenue (TRASK) is expected to rise between 8% to 10% in the first half of FY27 compared to the first half of FY26.

With the above in mind, the projection on Commsec suggests the business could deliver higher earnings but maintain its annual dividend per Qantas share at 39.6 cents. That would be a dividend yield of 4.25% and a grossed-up dividend yield of 6%, including franking credits.

FY28

In the next financial year, being FY28, analysts predict that the earnings and dividend could grow further.

According to the projection on Commsec, the ASX share could hike its annual dividend per Qantas share of 43.1 cents in FY28. That would be a grossed-up dividend yield of 6.6%, including franking credits, at the time of writing.

FY29

The 2029 financial year could be the best of all for this series of projections.

According to the estimate on Commsec, the business could pay an annual dividend per Qantas share of 49.6 cents. That would translate into a grossed-up dividend yield of 7.6%, including franking credits.

Overall, it seems like the airline could produce solid dividend returns in the coming years.

The post Here’s the dividend forecast out to 2029 for Qantas shares appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to buy next week
• Buy, hold, sell: Flight Centre, Qantas, and Wesfarmers shares
• 11 ASX 200 shares with reaffirmed buy ratings post-results
• Buying Qantas shares? Here’s what happened with the ASX 200 airline in August
• How many Qantas shares do I need to buy for $10,000 per year of passive income?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There is a group of ASX dividend shares that I believe will make great long-term investments for both capital growth and passive income over the long-term.

I’m so optimistic about certain names that I’ve invested in them for my own portfolio, and I’m planning to buy more in the coming months and years.

In my view, the names below are two of the most compelling passive income stocks right now.

L1 Global Long Short Fund Ltd (ASX: GLS)

This business is a listed investment company (LIC) and it’s a recent addition to my portfolio. It’s similar to the L1 Long Short Fund Ltd (ASX: LSF), except it only invests in global shares, rather than a mixture of ASX shares and global shares.

The globally-focused business focuses on company-specific opportunities where valuation and earnings delivery can drive returns across a “range of potential macro environments”.

In its monthly update for July 2026, it noted that its median ‘long’ position is trading on a price/earnings (P/E) ratio of 10, supported by double-digit earnings per share (EPS) growth and modest debt levels.

As its name suggests, the LIC can also short businesses, which essentially means it can bet on certain names in the portfolio going down in value. Therefore, it can make investment returns whether the market goes up or down.

The ASX dividend share can give Australian investors exposure to a diversified portfolio, with investments (and short positions) across North America, Europe and the Asia Pacific regions.

L1 Group Ltd (ASX: L1G) only started managing this LIC in November 2025, but its portfolio’s net return has been 17.9% since then, outperforming the global share market by 6.6% in that time.

The global LIC has provided dividend guidance of at least 8 cents per share in FY27, with quarterly dividends of 2 cents per share. It has also stated an intention to pay sustainable and growing dividends over time.

Its guidance implies a guided grossed-up dividend yield of at least 5.4%, including franking credits, at the time of writing.

Rural Funds Group (ASX: RFF)

Rural Funds is the other ASX dividend share I want to talk about. It’s a real estate investment trust (REIT) that provides exposure to a portfolio of agricultural properties.

The business offers a diversified portfolio across cattle, almonds, macadamias, vineyards and cropping.

The FY26 result highlighted the strength of the REIT’s ability to deliver good passive income despite challenging conditions in relation to higher interest rates.

Rural Funds reported that FY26 net property increase grew 5.7% thanks to additional rental income on capital expenditure (primarily macadamia orchards) and indexation. Its rental contracts have income growth from fixed annual increases and inflation-linked increases.

It also reported that adjusted funds from operations (AFFO) – the net rental profit – rose by 1.7%, despite interest costs increasing significantly.

The business has announced a few asset sales, at a premium to the stated book value, which will decrease interest costs and put the balance sheet in a healthier position. It had adjusted net asset value (NAV) of $3.22 as of June 2026 (which was a 4.5% rise year over year) – that means, it’s trading at a 40% discount to the stated value.

It expects to pay a distribution per unit of 11.73 cents in FY27, which is a distribution yield of 6%.

The post 2 great ASX dividend share buys for passive income in September appeared first on The Motley Fool Australia.

More reading

• 3 top ASX dividend shares to buy in September
• How much is needed in superannuation to target a $60,000 annual passive income?
• How much is needed in superannuation to target a $2,500 monthly passive income?
• How much do I need to retire on $120,000 a year at 55?
• Why Bell Potter rates these ASX dividend shares with 5% to 8% yields as buys

Motley Fool contributor Tristan Harrison has positions in L1 Global Long Short Fund Ltd, L1 Group, L1 Long Short Fund, and Rural Funds Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

While having recovered from their February one-year lows, Pro Medicus Ltd (ASX: PME) shares remain sharply lower over the past year.

On Monday afternoon, shares in the S&P/ASX 200 Index (ASX: XJO) health imaging company were trading for $170.11apiece. That sees the share price down a sharp 43.2% over 12 months, well behind the 1.9% gains posted by the benchmark index over this same period.

A lot of the pressure on Pro Medicus shares has come amid wider concerns that AI can potentially replace the services that many global Software as a Service (SaaS) companies provide.

You may have heard this called the ‘SaaSpocalypse’.

But following the big selldown, Medallion Financial Group’s Stuart Bromley believes Pro Medicus is now trading at “an attractive entry point” (courtesy of The Bull).

Here’s why.

Should I buy Pro Medicus shares today?

“Pro Medicus is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks,” Bromley said, citing the first reason he’s bullish on the ASX 200 healthcare stock.

As for the second reason you might want to buy Pro Medicus shares today, he said:

Revenue of $261.7 million in full year 2026 rose 22.9 per cent on the prior corresponding period. Underlying net profit after tax of $144.7 million was up 24.1 per cent. Revenue and underlying net profit exceeded expectations, while the underlying earnings before interest and tax margin reached an exceptional 74.9 per cent.

Then there’s the company’s solid revenue pipeline.

“It signed 10 new contacts worth $407 million in full year 2026. It renewed six contracts on five-year terms to the value of $141 million,” Bromley noted.

As for the fourth reason this ASX share is buy today, Bromley concluded, “Recent share price weakness provides an attractive entry point into a high-quality growth business.”

What’s the latest from the ASX 200 healthcare share?

Pro Medicus reported its FY 2026 results on 18 August.

Atop the strong financial results Bromley mentioned above, the company declared an all-time high final dividend of 37 cents per share, fully franked. It’s a bit too late to grab that record passive income payout, though. The stock traded ex-dividend yesterday.

Commenting on the company’s strong results on the day, Pro Medicus CEO Sam Hupert said:

We were aiming for 30% increases in EBIT and NPAT, and we exceeded both on a constant currency basis… Progress made in the cardiology market represents another important string to our bow. We see this trend continuing.

Pro Medicus shares closed up 11.9% on the day of the results release.

The post Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today appeared first on The Motley Fool Australia.

More reading

• Experts name 3 top ASX shares to buy this week
• Buy, hold, sell: Pro Medicus, BHP, CBA shares
• These ASX 50 shares have lost up to 60%. Is the sell-off overdone?
• 5 things to watch on the ASX 200 on Monday
• Top 3 ASX healthcare shares to buy after a brutal year

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.